Stroke Trials in Kaohsiung City, Taiwan
Conditions / Stroke / Kaohsiung City, Taiwan
Research into Stroke spans multiple therapeutic approaches and trial phases.
39 total trials for this combination
Showing top 10 of 39 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02065388 | Pharmacogenetic Dosing of Warfarin | COMPLETED | PHASE3 |
| NCT00790920 | Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | COMPLETED | PHASE3 |
| NCT00153062 | PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes | COMPLETED | PHASE4 |
| NCT07324278 | Hybrid Stroke Rehab With Mirror Priming | RECRUITING | NA |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00141011 | Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke | TERMINATED | PHASE3 |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |